Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onyee Chan

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Leukemia Research|July 30, 2019
Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC)Seongseok Yun, Rohit Sharma, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 22, 2023
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and OutcomesSara M Tinsley-Vance, Najla Al Ali, Somedeb Ball, et al.
American Journal of Hematology|February 18, 2022
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?Somedeb Ball, Akriti G Jain, Luis E Aguirre, et al.
Leukemia Research|December 21, 2022
Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patientsSomedeb Ball, Luis E Aguirre, Akriti G Jain, et al.
American Journal of Hematology|September 14, 2023
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemiaParth C Patel, Somedeb Ball, Akriti G Jain, et al.
Leukemia|February 25, 2025
Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasmNadia Gharaee, Joanna Wegrzyn-Woltosz, Jihong Jiang, et al.
Blood Advances|February 24, 2026
Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomesDavid A Sallman, Amy F McLemore, Rami Komrokji, et al.
American Journal of Hematology|January 27, 2021
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemiaDaniel R Richardson, David M Swoboda, Dominic T Moore, et al.
Blood Advances|November 25, 2025
Post-transplant MRD Monitoring by TP53 Duplex Sequencing with APR-246 + Azacitidine Maintenance Predicts OutcomesDavid A Sallman, Amy F McLemore, Rami S Komrokji, et al.
Annals of Hematology|July 2, 2026
Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024)Utsav Joshi, Fatima Tuz Zahra, Pujan Patel, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Leukemia Research|July 30, 2019
Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC)Seongseok Yun, Rohit Sharma, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 22, 2023
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and OutcomesSara M Tinsley-Vance, Najla Al Ali, Somedeb Ball, et al.
American Journal of Hematology|February 18, 2022
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?Somedeb Ball, Akriti G Jain, Luis E Aguirre, et al.
Leukemia Research|December 21, 2022
Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patientsSomedeb Ball, Luis E Aguirre, Akriti G Jain, et al.
American Journal of Hematology|September 14, 2023
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemiaParth C Patel, Somedeb Ball, Akriti G Jain, et al.
Leukemia|February 25, 2025
Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasmNadia Gharaee, Joanna Wegrzyn-Woltosz, Jihong Jiang, et al.
Blood Advances|February 24, 2026
Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomesDavid A Sallman, Amy F McLemore, Rami Komrokji, et al.
American Journal of Hematology|January 27, 2021
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemiaDaniel R Richardson, David M Swoboda, Dominic T Moore, et al.
Blood Advances|November 25, 2025
Post-transplant MRD Monitoring by TP53 Duplex Sequencing with APR-246 + Azacitidine Maintenance Predicts OutcomesDavid A Sallman, Amy F McLemore, Rami S Komrokji, et al.
Annals of Hematology|July 2, 2026
Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024)Utsav Joshi, Fatima Tuz Zahra, Pujan Patel, et al.
Pageof 8